About Taiwan Bio
Taiwan Bio. focuses on the innovation and widespread adoption of cell therapies. Through the FAST CGT platform, we effectively reduce costs, improve efficacy, accelerate development processes, and shorten production cycles, creating new milestones in the treatment of chronic and immune-related diseases. Starting from Taiwan, our technology is gradually expanding globally, and we are collaborating with several renowned U.S. universities and research institutions to build a complete industrial ecosystem.
With our unique TDM business model, we provide comprehensive support for cell therapy products in the preclinical or early clinical stages, covering everything from R&D to production. This enables more patients to benefit from cutting-edge cell therapies, ushering in a new era of health free from chronic diseases.
VIEW MORE
With our unique TDM business model, we provide comprehensive support for cell therapy products in the preclinical or early clinical stages, covering everything from R&D to production. This enables more patients to benefit from cutting-edge cell therapies, ushering in a new era of health free from chronic diseases.
Our Specialties
Next-generation cell therapy new drug development
Using the FAST CGT platform, we are building a new drug development database for cell therapies, combining cell engineering technologies to enhance cell functions, and focusing on breakthroughs in the treatment of severe chronic diseases.
Cell therapy design and manufacturing services
Leveraging the core advantages of the FAST CGT platform and our unique Therapeutics Design & Manufacturing (TDM) business model, we focus on providing one-stop professional services for cell therapy companies in the preclinical and early clinical stages.
Core Technology Platform
The FAST CGT platform combines technologies such as big data analysis, gene transfection design, cell engineering, gene modification, and automated manufacturing processes to achieve the goals of reducing cell therapy manufacturing costs, improving efficacy, accelerating development processes, and shortening production cycles. This platform provides precise and efficient solutions to industry pain points, driving innovation and widespread adoption of cell therapies, and supporting the robust development of the global cell therapy industry.
Our Vision
Make cell therapy benefit every patient worldwide, and together, step into a new era of better health and a future without chronic diseases
